Browse Indicators

Operations
Indicator title
(AGYW_PREV) Percentage of adolescent girls and young women (AGYW) that completed at least the DREAMS primary package of evidence-based services/interventions
(FPINT_SITE) Number of HIV service delivery points (SDP) at a site supported by PEPFAR that are providing integrated voluntary family planning (FP) services
HIV incidence
Estimates of the size of key populations (A–E)
(GEND_GBV) Number of people receiving post-gender-based violence (GBV) clinical care based on the minimum package
HIV prevalence among key populations (A-E)
(KP_MAT) Number of people who inject drugs (PWID) on medication-assisted therapy (MAT) for at least 6 months
(KP_PREV) Number of key populations reached with individual and/or small group-level HIV prevention interventions designed for the target population
HIV testing among key populations (A–D)
(OVC_SERV) Number of beneficiaries served by PEPFAR OVC programs for children and families affected by HIV
Condom use among sex workers
Condom use among gay and other men who have sex with men
Condom use among people who inject drugs
Condom use among transgender people
(PP_PREV) Number of priority populations (PP) reached with the standardized, evidence-based intervention(s) required that are designed to promote the adoption of HIV prevention behaviors and service uptake
Antiretroviral medicine stock-outs
Coverage of HIV prevention programmes among key populations (A–D)
HIV prevention programmes in prisons
(PrEP_CURR) Number of individuals, inclusive of those newly enrolled, that received oral antiretroviral pre- exposure prophylaxis (PrEP) to prevent HIV during the reporting period
Safe injecting practices among people who inject drugs
(PrEP_NEW) Number of individuals who were newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV infection in the reporting period
Needles and syringes distributed per person who injects drugs
(TB_PREV) Proportion of ART patients who started on a standard course of TB Preventive Treatment (TPT) in the previous reporting period who completed therapy
Coverage of opioid agonist maintenance therapy
People who received pre-exposure prophylaxis

Pages